文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

界定肥厚型心肌病的遗传结构:重新评估非肌节基因的作用

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes.
PubMed 文献 · Eur Heart J · 2017-01-01

研究对804例新发前瞻性肥厚型心肌病(HCM)患者及已发表的6179例临床基因分型HCM患者进行测序,并与外显子聚合联盟(ExAC)60706例参考人群比较31个HCM相关基因的变异。发现大多数非肌节基因的罕见蛋白改变变异并未显著超出对照,提示这些基因的新变异极少可解释为致病,肌节基因变异仍是目前已知HCM的主要病因。

要点

  • 在31个HCM相关基因中,多数非肌节基因的罕见蛋白改变变异并未显著超出对照。
  • 即使有既往共分离证据的基因(如ACTN2),其新变异也极少可解释。
  • 肌节基因变异仍是目前已知HCM的主要病因。

核心结论

  • 大多数与HCM相关的非肌节基因的遗传变异与HCM无关。
  • 肌节基因变异是目前已知HCM的主要病因。
  • 多数患者的HCM病因仍未知。

研究设计与样本

  • 对新发前瞻性HCM队列804例进行已知和推测HCM基因测序,并与已发表的最大临床基因分型HCM系列6179例、既往发表的HCM队列及ExAC参考人群60706例的数据联合分析,评估31个HCM相关基因的变异。

主要发现

  • 在多数受检基因中,罕见(ExAC中次要等位基因频率<1:10000)蛋白改变变异并未显著超出对照。
  • 即使对于有既往共分离证据的基因(如ACTN2),新变异也极少可解释。
  • 研究整合HCM基因序列数据与聚集的家系及功能数据,提出了评估HCM基因致病性的方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Hypertrophic cardiomyopathy (HCM) exhibits genetic heterogeneity that is dominated by variation in eight sarcomeric genes. Genetic variation in a large number of non-sarcomeric genes has also been implicated in HCM but not formally assessed. Here we used very large case and control cohorts to determine the extent to which variation in non-sarcomeric genes contributes to HCM. METHODS AND RESULTS: We sequenced known and putative HCM genes in a new large prospective HCM cohort (n = 804) and analysed data alongside the largest published series of clinically genotyped HCM patients (n = 6179), previously published HCM cohorts and reference population samples from the exome aggregation consortium (ExAC, n = 60 706) to assess variation in 31 genes implicated in HCM. We found no significant excess of rare (minor allele frequency < 1:10 000 in ExAC) protein-altering variants over controls for most genes tested and conclude that novel variants in these genes are rarely interpretable, even for genes with previous evidence of co-segregation (e.g. ACTN2). To provide an aid for variant interpretation, we integrated HCM gene sequence data with aggregated pedigree and functional data and suggest a means of assessing gene pathogenicity in HCM using this evidence. CONCLUSION: We show that genetic variation in the majority of non-sarcomeric genes implicated in HCM is not associated with the condition, reinforce the fact that the sarcomeric gene variation is the primary cause of HCM known to date and underscore that the aetiology of HCM is unknown in the majority of patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Walsh R, Buchan R, Wilk A, et al. Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes. Eur Heart J. 2017. PMID: 28082330. doi:10.1093/eurheartj/ehw603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。